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agers, pharmacy staff, and pharmacy clients. The target population of this study was 
community pharmacies settled in Tehran, the capital city of Iran. The managerial 
team of the invited pharmacies must remain unchanged for at least three years 
ending to the study. Manager’s and staff questionnaires contained questions about 
their job satisfaction, self assessment of knowledge, skills, and performance. Staff 
was also asked about manager’s behavior. Client’s questionnaire evaluated client’s 
satisfaction with the pharmacy. Confirmatory factor analysis and correlation test 
were performed using SPSS 16.0.0. Results: Data from 187 pharmacies was gath-
ered. Based on the results, applying strategy planning had significant relationship 
with financial (R= 0.204, p-value< 0.05) and societal results (R= 0.451, p-value < 0.01). 
Manager’s behavior was significantly (p-value < 0.01) correlated with society, staff 
and client result (R= 0.234, 0.674 and 0.307, respectively). Staff’s knowledge and 
skills was related with staff’s satisfaction (R= 0.211, p-value < 0.01), society (R= 0.339, 
p-value < 0.01) and financial (R= 172, p-value < 0.05) result, but client’s satisfaction 
correlation was only significant with technical pharmacist’s skills (R= 0.275) and 
non-pharmaceutical knowledge (communication, information exchange, and ethics) 
(R= 0.301). ConClusions: Although community pharmacies, in Iran, suffer from 
low professionalization and health policy makers’ inattention, results of this study 
are promising, because show that manger’s can still affect pharmacy achievements 
by improving their behavior, knowledge and skills.
PHP175
CHaraCter of toxiC Damage of Liver in infLuenCes of substanCes of 
meDiator to fetaL CeLLs on HePatoCytes in aCute Liver faiLure
Akhmetova Z, Zhanaliyeva M, Bukeyeva Z, Shaizadina G, Turgambayeva A
Astana Medical University, Astana, Kazakhstan
objeCtives: In a comparative analysis of the hepatoprotective properties of media-
tor substances fetal cells were more expression than in essentiale and provided 
dose-dependent effect. The aim was to evaluate the effect of mediator substances of 
fetal cells to hepatocytes during acute liver failure. Methods: For this experiment 
we used an experimental model of chronic hepatitis, where a carbon tetrachloride 
used as toxic agent, which were introduced into experimental rats at dose of 0,2ml 
/ 100g. The experiment had been lasted 45 days. Thus, the level of alanine ami-
notransferase at the 2nd day of the experiment in the control group of untreated 
animals was 4.6 times higher than in intact rats. While the level of aspartate ami-
notransferase in blood serum of control animals receiving no hepatoprotective 
therapy increased 1.8 times to 10thday as compared to intact group. Results: 
Experimental acute hepatitis accompanied by an increase in the values of thymol 
1.5 times already on the 2nd day, on the 5th and 10th days of the experience were 
even more growth in this indicator when it exceeded the level of the intact group 
by 3.9 times and amounted to respectively p< 0.05 and p < 0.001. In the control group 
of animals exposed to the toxic effects of paracetamol and its metabolites to liver 
cells was observed marked change parameters of cholestasis. Thus, the content of 
bilirubin in the group of untreated animals on the 2nd and 5th day of the experi-
ment exceeds the index of intact animals by 1.3 times, on the 10th day of the study, 
it decreased and was 1.2 lower than in the intact group (p< 0.001). ConClusions: 
Morphological findings which were found in the experimental groups using the 
“mediator substances” of fetal cells in a dose of 0.1 ml/kg, showed that their hepato-
protective effect appears to 10th days.
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objeCtives: Under Article 48 of Law 326/2003, AIFA has established an innovative 
funding scheme (Fondo AIFA 5%). Italian pharmaceutical companies are required 
to donate 5% of their promotional expenditure to an independent research fund. 
Half of this allowance is used for the reimbursement of orphan and life saving 
drugs awaiting market entry. This study is aimed to assess how many applications 
have been submitted to the Technical Committee of AIFA (CTS) and how they have 
been evaluated. Methods: The reports of CTS meetings from January 2013 to May 
2015 were reviewed, checking number and characteristics of drugs under evalua-
tion, and analysing each single decision taken by CTS. Results: Over the period 
under analysis, CTS evaluated 15 drugs, for the treatment of 61 patients. The thera-
peutic areas mainly represented were the respiratory system (cystic fibrosis), the 
onco-haematology (multiple myeloma and MCL) and other rare diseases (Duchenne 
muscular dystrophy, short-bowel syndrome, cystic fibrosis, inborn errors of primary 
bile acid synthesis). Out of 61 patient applications, 16 were approved, 26 rejected 
as the product obtained a full registration and reimbursement in the meantime, 8 
rejected (expanded access program or drug already included in 648 List), 6 rejected 
due to the lack of data or waiting CHMP’s decision, and 5 rejected due to technical 
reasons. ConClusions: AIFA has a very high engagement to assure patient access 
to orphan and life saving drugs. The 2014 fund amounted to 15,6 million Euro, half 
of it to be used for the reimbursement of orphan and life saving drugs awaiting 
market entry, whilst the other half aimed to support independent research, drug 
information programs and pharmacovigilance costs. However, having said this, the 
expenditure for the sole orphan and life saving drugs from the Fondo AIFA in 2014 
amounted only to 239.895 Euro.
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assesses the clinical effectiveness of generic CD SMS. Methods: An overview of 
reviews was deemed the most efficient approach to gather and summarise a large 
body of evidence, thereby efficiently informing clinical decision makers. Systematic 
reviews of RCTs and overviews of reviews assessing generic CD SMS interventions 
in adults were included. Assessment of included study quality was performed using 
the R-AMSTAR quality appraisal tool. Results: Generic CD SMS interventions com-
prise a heterogeneous group that have been assessed for a diverse range of chronic 
diseases and for which there is limited evidence of clinical effectiveness. Small 
reductions in health care utilisation are reported in a limited number of RCTs for 
CD self-management programmes and in a review of a range of generic SMS inter-
ventions. While there is a large quantity of evidence, generally low or unreported 
quality of included studies with typically short term follow-up leads to a high degree 
of uncertainty around results. ConClusions: The optimal format of generic SMS, 
the diseases in which it is likely to provide benefit, and the duration of effective-
ness, if any, remains unclear.
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objeCtives: The Emergency Department (ED) represents the most important entry 
point to hospital services. Variability and unpredictability in demand, the hetero-
geneity of clinical paths combined with an ongoing pressure to optimize the use 
of scarce resources have led to increasing issues such as ED crowding. The goal of 
the current study is to assess the impact of shorter protocol times for the clus-
ter of ED patients who present with chest pain on ED Key Performance Indicators 
(KPI). Methods: A model based on a queuing theory has been developed and has 
been tested in a hypothetical ED with 20 chest pain patients (CPP) per day. The 
management of CPP mainly relies on serial measurements of troponin at defined 
time points. The model has been tested in two scenarios, one characterized by 
the use of a traditional troponin tests (6 hours protocol time), and one character-
ized by the use of high sensitivity troponin test (3 hours protocol time as recently 
recommended by clinical guidelines). In order to measure the impact of a shorter 
protocol time in the ED, we compare the ED KPIs resulting from the model in the two 
scenarios. Results: The benchmark between the two scenarios shows an improve-
ment of all ED KPIs for the scenario with a shorter protocol time: a reduction of (i) ED 
diversion rate (diff. 5.1%), (ii) ED waiting time (- 79%), (iii) ED length of stay (- 66%); 
a daily increase of (i) ED bed availability (+2.2 beds) and (ii) ED admission rate (+1 
patient). ConClusions: A reduction in protocol time for chest pain patients would 
improve KPIs for this cluster of patients. As a subsequent impact other patients 
would benefit from released capacity which could alleviate ED flow issues in general. 
Future studies are going to validate the ED model.
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objeCtives: A Periodic Safety Update Report (PSUR) is intended to provide an 
update of the worldwide safety experience of a medicinal product to competent 
regulatory authorities at defined time points post-authorization. Drug Controller 
General of India (DCGI) has taken initiatives for enforcing the submission of 
PSURs from hospitals throughout the country for drugs launched 2011 onwards. 
This data would be used to validate the accuracy/bias of the PSURs submitted by 
pharmaceutical companies. In this study the assessment and validation of the 
impact of PSUR system implementation and its functioning in the hospital was 
carried out. Methods: Retrospective and prospective observational study for 
ADR reporting of three commonly prescribed drugs in the hospital for the period 
of 9 months before and 9 months after the PSUR system implementation in the 
hospital. Results: Amlodipine, Furosemide and Risperidone are three commonly 
prescribed drugs in different wards of hospital. A total of 65 ADRs were reported for 
the period of March-November 2013, in which 10(2%), 40(5.69%) and 15(6.12%) ADRs 
were reported for Amlodipine, Furosemide and Risperidone respectively. There was 
a 60% rise in ADR reporting rate observed after implementation of PSUR system 
in the hospital. 107 ADRs were reported for the period of December-August 2014, 
out of which 20(4.62%), 62(9%) and 25(10%) ADRs were reported for Amlodipine, 
Furosemide and Risperidone respectively. ConClusions: This study showed that 
implementation of PSUR system for reporting of ADRs in the hospital works as a 
great tool for effective pharmacovigilance. PSUR reporting through hospital is a great 
initiative directed through DCGI, India. By following PSUR practice in a hospital, 
we can encourage more health care professionals to get involved in ADR reporting 
program for the safety and wellbeing of mankind.
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objeCtives: This study tried to find out whether the level of knowledge and skills 
of people working in a community pharmacy and applying strategy planning in 
community pharmacies, in Iran, can affect their achievements, as small to medium 
sized enterprises working in a circumstance with little professionalization of com-
munity pharmacies activities. Methods: In 2015, a cross-sectional survey was 
conducted using self-administered, anonymous questionnaires designed for man-
